Cambridge, MA – According to filings with the U.S. Securities and Exchange Commission, Travera LLC is raising $7,850,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Clifford Reid played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Travera LLC

Travera was founded in 2017 to commercialize a breakthrough measurement technology and biomarker developed in the Manalis Laboratory in the Koch Institute for Integrative Cancer Research at MIT.  The core technology, a MEMS device called the Suspended Microchannel Resonator (SMR), is an exquisitely sensitive scale that can measure a small change in the weight of a single cancer cell.

To learn more about Travera LLC, visit http://travera.com/

Contact:
Clifford Reid, Chief Executive Officer
650-576-7738
https://www.linkedin.com/in/cliff-reid-1ba18/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved